The House Ethics Committee has recommended censuring a North Carolina congressman following allegations of inappropriate behavior toward female staff members.
Wildfire Smoke Spreads Across the Pacific Northwest and Beyond
Smoke from wildfires in the Pacific Northwest is spreading across the region, affecting air quality in cities like Portland and Denver. Air health advisories have been issued.
Oil Prices Rise Amid Geopolitical Tensions in Strait of Hormuz
Oil prices climbed amid escalating tensions in the Strait of Hormuz, with Iran claiming downed drones and diplomatic efforts underway.
CNH Reports Strong Q2 Earnings Amid Challenging Agricultural Market Conditions
CNH delivers strong second-quarter results despite difficult conditions in agriculture. Company shows improved outlook for the year ahead.
US and Japan Coordinate Currency Intervention to Stabilize Yen
Washington and Tokyo have jointly intervened in the currency market to support the weakening yen. The move aims to reduce volatility and protect global financial stability.
Palantir Surpasses Financial Expectations as AI Platform Drives Strong Growth
Palantir’s second-quarter results exceeded Wall Street expectations, with strong revenue growth and a bullish outlook driving stock surges.
OpenAI’s Influencer Retreat Sparks Backlash Over Luxury Getaway Amid AI Controversy
OpenAI hosted influencers at a luxury retreat, sparking criticism over the contrast between AI’s environmental impact and the lavish event.
Michigan Reports First Two Deaths Linked to Cyclosporiasis Outbreak
Michigan has reported two deaths linked to a cyclosporiasis outbreak. The illness, caused by contaminated food, is usually not fatal but can be serious for those with weakened immune systems.
NHS Patient Data Access Under Scrutiny Amid Supplier Involvement
The NHS is facing scrutiny over how patient data is accessed by external suppliers, particularly Palantir. An apology was issued after an error in a transparency document.
AstraZeneca and Bristol Myers Squibb Explore Merger Talks
AstraZeneca and Bristol Myers Squibb are reportedly exploring a potential merger. The talks come amid shifting strategies in the pharmaceutical industry.
